CONCLUSION
By examining follow-up data in patients with suspected ACEi-AE, our study revealed that misdiagnosis is frequent in this population. Patients with a diagnosis of ACEi-AE confirmed by follow-up had attacks that could display characteristics classically associated with histamine-mediated AE and were responsive to icatibant. These results need to be confirmed on prospective studies performed on larger cohorts.